Week in Review
ArGen-X BV raised $37.1 million in a Series B round.
Celsion Corp. is raising $15 million in a private placement of stock and warrants.
Inhibitex Inc. raised $20 million through an at-the-market offering.
NuCana BioMed Ltd. raised $10.5 million in a Series A round for anticancer nucleoside analogues.
Oxigene Inc. established a $20 million standby equity purchase agreement.
Suite: 1100 | Atlanta, Georgia 30346, USA
In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-770-810-3144
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter